(Q37605790)

21 August 2017

1 reference

title

Clinical application of proteomics in ovarian cancer prevention and treatment (English)

1 reference

21 August 2017

1 reference

3

Lance Liotta

1 reference

21 August 2017

Francesco Meani

1

1 reference

21 August 2017

Sergio Pecorelli

series ordinal

2

1 reference

21 August 2017

Emanuel F Petricoin

series ordinal

4

1 reference

21 August 2017

publication date

1 January 2009

1 reference

Molecular Diagnosis and Therapy

21 August 2017

published in

1 reference

21 August 2017

volume

13

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

297-311

1 reference

Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Proteomics in clinical trials and practice: present uses and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Human body fluid proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Discovery of urinary biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Proteins' promise--progress and challenges in ovarian cancer proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

The blood peptidome: a higher dimension of information content for cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Glycopeptide analysis by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Serum and plasma proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: Implication of multiple injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Microarray methods for protein biomarker detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

An investigation into the human serum "interactome"

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Analysis of albumin-associated peptides and proteins from ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Characterization of the low molecular weight human serum proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Unraveling the complexity of circulating forms of brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Concentration and Preservation of Very Low Abundance Biomarkers in Urine, such as Human Growth Hormone (hGH), by Cibacron Blue F3G-A Loaded Hydrogel Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Interaction of sugars, polysaccharides and cells with boronate-containing copolymers: from solution to polymer brushes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

The tumor microenvironment: key to early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Applications of antibody array platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

A portrait of tissue phosphoprotein stability in the clinical tissue procurement process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Serum protein markers for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Biomarker discovery for ovarian cancer using SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Proteomics profile changes in cisplatin-treated human ovarian cancer cell strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Use of proteomic analysis to monitor responses to biological therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Clinical proteomics: Written in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Progress and challenges in screening for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256335

Laser-capture microdissection

21 January 2018

1 reference

12 December 2020

Searching for potential biomarkers of cisplatin resistance in human ovarian cancer using a label-free LC/MS-based protein quantification method

1 reference

12 December 2020

Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.

1 reference

12 December 2020

Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer

1 reference

12 December 2020

A prospective analysis of imatinib-induced c-kit modulation in ovarian cancer

1 reference

12 December 2020

Reverse phase protein microarrays for monitoring biological responses

1 reference

12 December 2020

Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.

1 reference

12 December 2020

Status of Tumor Markers in Ovarian Cancer Screening

1 reference

12 December 2020

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial

1 reference

12 December 2020

Screening for Ovarian Cancer

1 reference

12 December 2020

CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

1 reference

12 December 2020

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

12 December 2020

Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256335

1 reference

21 August 2017

1 reference